News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
1Bitget UEX Daily | Trump Does Not Rule Out Sending Troops to Iran; Iran Closes Strait of Hormuz, Oil Prices Soar; Drone and Space Stocks Rise Collectively (2026/03/03)2Bitcoin slide slowing, but bear market still in play: Analysts3Research Report｜In-Depth Analysis and Market Cap of Opinion Labs (OPN)
IBM Shares Rally 2.47 Claw Into Top 70 by Dollar Volume Driven by Earnings Beats and Dividend Hike
101 finance·2026/03/03 22:39
GE Aerospace Shares Drop 3.36% Even With Robust Profits, Placing 60th Amid $1.84B Trading Volume Spike
101 finance·2026/03/03 22:39
NRG Energy Shares Drop 7.7% as Secondary Offering Triggers $1.86 Billion Trading Volume, Placing at 59th
101 finance·2026/03/03 22:36
Trump: GENIUS stablecoin law 'threatened' by banks as Congress stalls on passing market structure bill
The Block·2026/03/03 22:36
Dell Shares Plummet 5.45% Despite 20% Dividend Hike $2.15B Volume Ranks 46th
101 finance·2026/03/03 22:31
Best "Strong Buy" Stocks to Consider Purchasing This March
101 finance·2026/03/03 22:30
Flash
22:25
Data: 10 million MOVE transferred out from Movement Network, worth approximately $2.21 million.ChainCatcher news, according to Arkham data, at 06:19, 10 million MOVE (worth approximately $2.21 million) were transferred from Movement Network to Null Address.
22:14
According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), ABVC BioPharma, Inc. has identified significant deficiencies in its internal control over financial reporting for the fiscal year 2025.This disclosure has raised concerns in the market regarding the company's financial transparency and governance structure. The company stated that it is actively taking measures to strengthen its internal control mechanisms in order to improve the accuracy and reliability of its financial information.
22:14
According to the latest filing submitted to the U.S. Securities and Exchange Commission (SEC), ABVC BioPharma, Inc. has identified significant deficiencies in its internal control over financial reporting for the fiscal year 2025.This disclosure has raised concerns in the market regarding the company's financial transparency and governance structure. The company stated that it is actively taking measures to strengthen its internal control mechanisms in order to improve the accuracy and reliability of its financial information.
News